All filters
Slidesets
Management of Toxicities from Immunotherapy: an ESMO Clinical Practice Guideline | Caroline O'Leary, BA (Hons), MSc (LSE), MB BCh BAO (Hons), MRCPI
Presented at:
Pharmacological Optimization of Lung Cancer Treatment Webinar: Drug-Drug Interactions, Therapeutic Drug Monitoring, and Immunotherapy
Slidesets
Therapeutic Drug Monitoring of Small Molecule Inhibitors in Patient with Lung Cancer: Ready for the Clinic? | Markus Jörger, MD, PhD, ClinPharm
Presented at:
Pharmacological Optimization of Lung Cancer Treatment Webinar: Drug-Drug Interactions, Therapeutic Drug Monitoring, and Immunotherapy
Slidesets
Drug-Drug Interactions between Small Molecule Inhibitors with Directly-Acting Oral Anti-coagulants (DOACs) in Patients with Lung Cancer. | Lorenz Van der Linden, PharmD, PhD
Presented at:
Pharmacological Optimization of Lung Cancer Treatment Webinar: Drug-Drug Interactions, Therapeutic Drug Monitoring, and Immunotherapy
Slidesets
Pharmacokinetics of Sofosbuvir-Based Direct Acting Antivirals for HCV in Pregnancy | Catherine Chappell
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023
Slidesets
Temporal Changes in Dolutegravir and Raltegravir Glucuronide Metabolite to Parent Ratios | Tim Cressey
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023
Slidesets
Tissue-Specific Pharmacology Knowledge and Knowledge Gaps | Charles Flexner
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023
Slidesets
New(er) Antiretrovirals in Pregnancy and Breastfeeding | Catriona Waitt
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023
Slidesets
Management of Antiplatelet/DOAC DDIS (Pk/PD) - in Context of HIV, HCV, COVID Antiviral Therapy | Mike Emerson
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023
Slidesets
A Year of CAB/RPV Use, What Have We Learned in the Real World | Emma Rubenstein
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023
Slidesets
Is TDM Still Needed / Useful ? | Nancy Sheehan
Presented at:
International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs 2023
Slidesets
Platelet Count to Spleen Diameter Ratio as a Predictor of Oesophageal Varices in Patients with Liver Cirrhosis at Muhimbili National Hospital Dar es Salaam, Tanzania
Presented at:
Conference on Liver Disease in Africa (COLDA) 2023
Slidesets
Molecular Characterization of Hepatitis B Virus Infection in HIV Infected Adults On Antiretroviral Therapy in Nairobi, Kenya
Presented at:
Conference on Liver Disease in Africa (COLDA) 2023
Slidesets
A Hepatitis B Virus Dual Point-of-Care Test Strategy to Identify Treatment-Eligible Patients in Africa
Presented at:
Conference on Liver Disease in Africa (COLDA) 2023
Slidesets
A New Player in the Management of Liver Disease in Sub-Saharan Africa - The Tanzania IR Experience - Erick Mbuguje, MD.pdf
Presented at:
Conference on Liver Disease in Africa (COLDA) 2023
Slidesets
A Global Action Agenda for Turning the Tide on Fatty Liver Disease - Wendy Spearman, MBChB, FCP, FRCP, MMed, PhD.pdf
Presented at:
Conference on Liver Disease in Africa (COLDA) 2023
Slidesets
Assessment of Hepatocellular Carcinoma Differences in Urban and Rural Africa Through Satellite Imaging Analysis - Jose Debes.pdf
Presented at:
Conference on Liver Disease in Africa (COLDA) 2023
Slidesets
African CDC - Growing Portfolio of Hepatitis-Related Activities - Hanna Amanuel Tesfahunei, MSc.pdf
Presented at:
Conference on Liver Disease in Africa (COLDA) 2023
Slidesets
Barriers to Implementation_Access to Care - Danjuma K. Adda, MPH, FIMS, Dip-IMS.pdf
Presented at:
Conference on Liver Disease in Africa (COLDA) 2023
Slidesets
Bilharzia and Viral Hepatitis - Imam Waked, MD, FRCP, FAASLD.pdf
Presented at:
Conference on Liver Disease in Africa (COLDA) 2023
Slidesets
Compared to the Wild-type, the G1862T Mutant of Hepatitis B Virus (HBV) Induces Upregulation of Fibronectin Expression and Wntβ--catenin Pathway in Vitro .pdf
Presented at:
Conference on Liver Disease in Africa (COLDA) 2023
Slidesets
Effectiveness of Tenofovir Prophylaxis for the Prevention of Mother-To-Child- Transmission of Hepatitis B Virus in Burkina Faso - Serge Ouoba.pdf
Presented at:
Conference on Liver Disease in Africa (COLDA) 2023
Slidesets
Establishing the Hepatitis B and C Prevention and Management Program - Malawi’s Experience - Wongani Mzumara.pdf
Presented at:
Conference on Liver Disease in Africa (COLDA) 2023
Slidesets
Fatty Liver Disease and Its Correlates Among People Living with HIV Attending Care and Treatment Clinic at Temeke Regional Referral Hospital, Dar es Salaa.pdf
Presented at:
Conference on Liver Disease in Africa (COLDA) 2023